Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
For the first time a semaglutide weight loss drug has been approved for use in Australia to also treat cardiovascular disease in obese and overweight patients.
A beloved company that has been part of the fabric of the US and has served hundreds of millions of customers around the ...